dihexa safety concerns hgf c-met cancer risk Frontiers Anti-cancer therapeutic strategies based on
Anti cancer therapeutic strategies based on HGF MET, EpCAM, and tumor stromal cross talk Cancer Cell International Springer Nature Link Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Developing c MET pathway inhibitors for cancer therapy: progress and challenges: Trends in Molecular Medicine Targeting c MET Alterations in Cancer: A Review of Genetic Drivers and Therapeutic Implications PMC
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 15 - Sep 20




